← Back to Search

Procedure

Sofwave for Cellulite

N/A
Waitlist Available
Research Sponsored by Sofwave Medical LTD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post treatment follow-up visit
Awards & highlights
No Placebo-Only Group

Summary

This trial uses a device called the SofWave System to treat patients' upper thighs and/or buttocks. The device sends energy into the skin to improve its appearance or health.

Eligible Conditions
  • Cellulite

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post treatment follow-up visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post treatment follow-up visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Measure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CelluliteExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sofwave
2020
Completed Phase 3
~240

Find a Location

Who is running the clinical trial?

Sofwave Medical LTDLead Sponsor
10 Previous Clinical Trials
582 Total Patients Enrolled
1 Trials studying Cellulite
69 Patients Enrolled for Cellulite

Media Library

Sofwave (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05882721 — N/A
Cellulite Research Study Groups: Cellulite
Cellulite Clinical Trial 2023: Sofwave Highlights & Side Effects. Trial Name: NCT05882721 — N/A
Sofwave (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05882721 — N/A
Cellulite Patient Testimony for trial: Trial Name: NCT05882721 — N/A
~21 spots leftby Dec 2025